272 related articles for article (PubMed ID: 7188126)
21. Drug therapy for peripheral arterial disease.
Naide D
Am Fam Physician; 1986 Sep; 34(3):215-7. PubMed ID: 3751848
[No Abstract] [Full Text] [Related]
22. The effect of pentoxifylline on circulatory disturbances of the retina and optic nerve. A report of ten years clinical experience.
Küchle HJ; Richard G
Ric Clin Lab; 1981; 11 Suppl 1():333-43. PubMed ID: 7188121
[TBL] [Abstract][Full Text] [Related]
23. [Intravenous pentoxifylline in Fontaine stage II and III peripheral arterial diseases].
Giansante C; Di Chiara A; Fiotti N; Mauri F; Sorrentino A; Spanghero M; Tomasin L; Calabrese S
Clin Ter; 1990 Sep; 134(5):301-5. PubMed ID: 2149312
[TBL] [Abstract][Full Text] [Related]
24. [Whole blood viscosity in patients with acral arterial occlusive diseases and their modification by rheologically active drugs].
Runge E; Thiele P
Z Gesamte Inn Med; 1987 Mar; 42(5):137-41. PubMed ID: 3590891
[TBL] [Abstract][Full Text] [Related]
25. Clinical considerations and treatment of diabetic angiopathy.
Nobbe F
J Med; 1979; 10(5):365-79. PubMed ID: 393791
[No Abstract] [Full Text] [Related]
26. Pentoxifylline treatment in patients with occlusive peripheral arterial disease. Circulatory changes and effects on prostaglandin synthesis.
Poggesi L; Scarti L; Boddi M; Masotti G; Serneri GG
Angiology; 1985 Sep; 36(9):628-37. PubMed ID: 3901827
[TBL] [Abstract][Full Text] [Related]
27. [Clinical evaluation of the preparation Trental].
Wesołowski J; Hubl S; Szubski J; Weinzieher E; Rykowski H
Wiad Lek; 1985 Apr; 38(8):551-5. PubMed ID: 3892924
[No Abstract] [Full Text] [Related]
28. [Serum lipid levels in patients with arteriosclerosis obliterans of the legs during treatment with pentoxifylline].
Kuczyńska K; Zebrowski M; Kancelarczyk WL; Rymaszewski Z
Pol Tyg Lek; 1988 Aug; 43(34):1092-4. PubMed ID: 3075031
[No Abstract] [Full Text] [Related]
29. [5 years of clinico-experimental and therapeutic experiences with pentoxifylline].
Lehrach F; Müller R; Theis H
Med Monatsschr; 1977 Apr; 31(4):159-63. PubMed ID: 853994
[No Abstract] [Full Text] [Related]
30. [Intermittent claudication treated with pentoxifylline. A controlled trial].
Skovborg F; Bonde-Petersen F; Bloch I; Christensen E
Ugeskr Laeger; 1983 Nov; 145(47):3649-52. PubMed ID: 6362159
[No Abstract] [Full Text] [Related]
31. Studies of the clinical pharmacology and therapeutic efficacy of pentoxifylline in peripheral obstructive arterial disease.
Di Perri T; Carandente O; Vittoria A; Guerrini M; Messa GL
Angiology; 1984 Jul; 35(7):427-35. PubMed ID: 6540539
[TBL] [Abstract][Full Text] [Related]
32. Beneficial hemorheologic therapy of chronic peripheral arterial disorders with pentoxifylline: results of double-blind study versus vasodilator-nylidrin.
Accetto B
Am Heart J; 1982 May; 103(5):864-9. PubMed ID: 7041579
[TBL] [Abstract][Full Text] [Related]
33. Comparative evaluation of the effectiveness of buflomedil and pentoxifylline in patients with arterial occlusive disease.
Trübestein G; Trübestein R; Duong QD
Angiology; 1981 Oct; 32(10):705-10. PubMed ID: 7034591
[TBL] [Abstract][Full Text] [Related]
34. Failure of pentoxifylline for end-stage peripheral vascular disease.
Loyd RG; Prian GW; Gomez H; Laub J; Mertz GH
Angiology; 1987 Apr; 38(4):304-8. PubMed ID: 3578918
[TBL] [Abstract][Full Text] [Related]
35. [Conservative treatment of trophic leg ulcers with trental].
Dvorkin SB; Chernookiĭ GP
Vestn Dermatol Venerol; 1985 Apr; (4):51-2. PubMed ID: 4002848
[No Abstract] [Full Text] [Related]
36. Haemorrheological improvement by pentoxifylline in patients with peripheral arterial occlusive disease.
Perego MA; Sergio G; Artale F; Giunti P; Danese C
Curr Med Res Opin; 1986; 10(2):135-8. PubMed ID: 3709212
[TBL] [Abstract][Full Text] [Related]
37. [Peripheral macro-and microcirculatory changes in acute arterial obstruction with papaverine and trental administration].
Koshkin VM; Adil'khanov SG; Antonova NIu
Vestn Khir Im I I Grek; 1979 Dec; 123(12):56-60. PubMed ID: 524688
[TBL] [Abstract][Full Text] [Related]
38. Pentoxifylline treatment of moderate to severe chronic occlusive arterial disease.
Lee BY; Berkowitz P; Savitsky JP; May GS; Brobst J; McCann WJ
Clin Cardiol; 1985 Mar; 8(3):161-5. PubMed ID: 3978888
[TBL] [Abstract][Full Text] [Related]
39. [Treatment of vascular diseases of the extremities using pentoxifylline].
Di Perri T
Ric Clin Lab; 1988; 18 Suppl 2():49-56. PubMed ID: 3073515
[No Abstract] [Full Text] [Related]
40. [Venous obstruction plethysmographic studies on the "borrowing-lending phenomenon" during use of pentoxifyllin and naftidrofuryl].
Heidrich H; Schartl M
Verh Dtsch Ges Inn Med; 1978; (84):1403-6. PubMed ID: 741978
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
